Human T-cell leukemia virus type I Tax transactivates the promoter of human prointerleukin-1β gene through association with two transcription factors, nuclear factor-interleukin-6 and Spi-1

Blood

Volumn 90, Issue 8, 1997, Pages 3142-3153

  Tsukada, Junichi ^a   Misago, Masahiro ^b   Serino, Yoko ^b   Ogawa, Ryosuke ^b   Murakami, Syuichi ^b   Nakanishi, Masatsugu ^b   Tonai, Shinichi ^b   Kominato, Yoshihiko ^b   Morimoto, Isao ^b   Auron, Philip E ^b   Eto, Sumiya ^b  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DNA BINDING PROTEIN; DNA FRAGMENT; INTERLEUKIN 6; RECOMBINANT PROTEIN; TAX PROTEIN; TRANSCRIPTION FACTOR; VIRUS PROTEIN;

ARTICLE; BINDING SITE; CONTROLLED STUDY; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; LEUKEMOGENESIS; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; T CELL LEUKEMIA; TRANSACTIVATION; TRANSCRIPTION REGULATION;

EID: 0030762123     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v90.8.3142     Document Type: Article

References (65)

1. Sakai M, Eguchi K, Terada K, Nakashima M, Yamashita I, Ida H, Kawabe Y, Aoyagi T, Takino H, Nakamura T, Nagataki S: Infection of human synovial cells by human T cell lymphotropic virus type I. Proliferation and granulocyte/macrophage colony-stimulating factor production by synovial cells. J Clin Invest 92:1957, 1993
2. Longo DL, Gelmann EP, Cossman J, Young RA, Gallo RC, O'Brien SJ, Malis LA: Isolation of HTLV-transformed B-lymphocyte clone from a patient with HTLV-associated adult T-cell leukaemia. Nature 310:505, 1984
3. Ho DD, Rota TR, Hirsch MS: Infection of human endothelial cells by human T-lymphotropic virus type I. Proc Natl Acad Sci USA 81:7588, 1984
4. de Revel T, Mabondzo A, Gras G, Delord B, Roques P, Boussin F, Neveux Y, Bahuau M, Fleury HJ, Dormont D: In vitro infection of human macrophages with human T-cell leukemia virus type 1. Blood 81:1598, 1993
5. Yoshikura H, Nishida J, Yoshida M, Kitamura Y, Takaku F, Ikeda S: Isolation of HTLV derived from Japanese adult T-cell leukemia patients in human diploid fibroblast strain IMR90 and the biological characters of the infected cells. Int J Cancer 33:745, 1984
6. Koyanagi Y, Itoyama Y, Nakamura N, Takamatsu K, Kira J, Iwamasa T, Goto I, Yamamoto N: In vivo infection of human T-cell leukemia virus type I in non-T cells. Virology 196:25, 1993
7. Ishiguro N, Abe M, Seto K, Sakurai H, Ikeda H, Wakisaka A, Togashi T, Tateno M, Yoshiki T: A rat model of human T lymphocyte virus type I (HTLV-I) infection. 1. Humoral antibody response, provirus integration, and HTLV-I-associated myelopathy/tropical spastic paraparesis-like myelopathy in seronegative HTLV-I carrier rats. J Exp Med 176:981, 1992
8. Arima N, Daitoku Y, Hidaka S, Yamamoto Y, Fujimoto K, Matsushita K, Ohtsubo H, Fukumori J, Tanaka H, Onoue K: Interleukin-2 production by primary adult T cell leukemia tumor cells is macrophage dependent. Am J Hematol 41:258, 1992
9. Sodroski JG, Rosen CA, Haseltine WA: Trans-acting transcriptional activation of the long terminal repeat of human T lymphotropic viruses in infected cells. Science 225:381, 1984
10. Seiki M, Inoue J, Takeda T, Hikikoshi A, Sato M, Yoshida M: The p40x of human T-cell leukemia virus type I is a trans-acting activator of viral gene transcription. Jpn J Cancer Res 76:1127, 1985
11. Seiki M, Inoue J, Takeda T, Yoshida M: Direct evidence that p40x of human T-cell leukemia virus type I is a trans-acting transcriptional activator. EMBO J 5:561, 1986
12. Mori N, Prager D: Transactivation of the interleukin-1α promoter by human T-cell leukemia virus type I and type II Tax proteins. Blood 87:3410, 1996
13. Siekevitz M, Feinberg MB, Holbrook N, Wong SF, Greene WC: Activation of interleukin 2 and interleukin 2 receptor (Tac) promoter expression by the trans-activator (tat) gene product of human T-cell leukemia virus, type I. Proc Natl Acad Sci USA 84:5389, 1987
14. Maruyama M, Shibuya H, Harada H, Hatakeyama M, Seiki M, Fujita T, Inoue J, Yoshida M, Taniguchi T: Evidence for aberrant activation of the interleukin-2 autocrine loop by HTLV-1-encoded p40x and T3/Ti complex triggering. Cell 48:343, 1987
15. Ejima E, Rosenblatt JD, Massari M, Quan E, Stephens D, Rosen CA, Prager D: Cell-type-specific transactivation of the parathyroid hormone-related protein gene promoter by the human T-cell leukemia virus type I (HTLV-I) tax and HTLV-II tax proteins. Blood 81:1017, 1993
16. Fujii M, Sassone CP, Verma IM: c-fos promoter trans-activation by the taxi protein of human T-cell leukemia virus type I. Proc Natl Acad Sci USA 85:8526, 1988
17. Mori N, Shirakawa F, Shimizu H, Murakami S, Oda S, Yamamoto K, Eto S: Transcriptional regulation of the human interleukin-6 gene promoter in human T-cell leukemia virus type I-infected T-cell lines: Evidence for the involvement of NF-κB. Blood 84:2904, 1994
18. Mori N, Murakami S, Oda S, Prager D, Eto S: Production of interleukin 8 in adult T-cell leukemia cells: Possible transactivation of the interleukin 8 gene by human T-cell leukemia virus type I tax. Cancer Res 55:3592, 1995
19. Fujisawa J, Seiki M, Sato M, Yoshida M: A transcriptional enhancer sequence of HTLV-I is responsible for trans-activation mediated by p40 chi HTLV-I. EMBO J 5:713, 1986
20. Leung K, Nabel GJ: HTLV-1 transactivator induces interleukin-2 receptor expression through an NF-κB-like factor. Nature 333:776, 1988
21. Suzuki T, Hirai H, Fujisawa J, Fujita T, Yoshida M: A trans-activator Tax of human T-cell leukemia virus type 1 binds to NF-κB p50 and serum response factor (SRF) and associates with enhancer DNAs of the NF-κB site and CArG box. Oncogene 8:2391, 1993
22. Perini G, Wagner S, Green MR: Recognition of bZIP proteins by the human T-cell leukaemia virus transactivator Tax. Nature 376:602, 1995
23. Wagner S, Green MR: HTLV-I Tax protein stimulation of DNA binding of bZIP proteins by enhancing dimerization. Science 262:395, 1993
24. Baranger AM, Palmer CR, Hamm MK, Giebler HA, Brauweiler A, Nyborg JK, Schepartz A: Mechanism of DNA-binding enhancement by the human T-cell leukaemia virus transactivator Tax. Nature 376:606, 1995
25. Hirai H, Suzuki T, Fujisawa J, Inoue J, Yoshida M: Tax protein of human T-cell leukemia virus type I binds to the ankyrin motifs of inhibitory factor κB and induces nuclear translocation of transcription factor NF-κB proteins for transcriptional activation. Proc Natl Acad Sci USA 91:3584, 1994
26. Kwok RP, Laurance ME, Lundblad JR, Goldman PS, Shih H, Connor LM, Marriott SJ, Goodman RH: Control of cAMP-regulated enhancers by the viral transactivator Tax through CREB and the co-activator CBP. Nature 380:642, 1996
27. Dinarello CA: Interleukin-1 and interleukin-1 antagonism. Blood 77:1627, 1991
28. Dinarello CA: The biological properties of interleukin-1. Eur Cytokine Netw 5:517, 1994
29. Tendler CL, Greenberg SJ, Burton JD, Danielpour D, Kim SJ, Blattner WA, Manns A, Waldmann TA: Cytokine induction in HTLV-I associated myelopathy and adult T-cell leukemia: Alternate molecular mechanisms underlying retroviral pathogenesis. J Cell Biochem 46:302, 1991
30. Dhib JS, Hoffman PM, Yamabe T, Sun D, Xia J, Eisenberg H, Bergey G, Ruscetti FW: Extracellular human T-cell lymphotropic virus type I Tax protein induces cytokine production in adult human microglial cells. Ann Neurol 36:787, 1994
31. Auron PE, Webb AC: Interleukin-1: A gene expression system regulated at multiple levels. Eur Cytokine Netw 5:573, 1994
32. Kominato Y, Galson D, Waterman WR, Webb AC, Auron PE: Monocyte expression of the human prointerleukin 1β gene (IL1B) is dependent on promoter sequences which bind the hematopoietic transcription factor Spi-1/PU.1. Mol Cell Biol 15:59, 1995
33. Clark BD, Collins KL, Gandy MS, Webb AC, Auron PE: Genomic sequence for human prointerleukin 1 beta: Possible evolution from a reverse transcribed prointerleukin 1 alpha gene [published erratum appears in Nucleic Acids Res 15:868, 1987]. Nucleic Acids Res 14:7897, 1986
34. Shirakawa F, Saito K, Bonagura CA, Galson DL, Fenton MJ, Webb AC, Auron PE: The human prointerleukin 1β gene requires DNA sequences both proximal and distal to the transcription start site for tissue-specific induction. Mol Cell Biol 13:1332, 1993
35. Tsukada J, Saito K, Waterman WR, Webb AC, Auron PE: Transcription factors NF-IL6 and CREB recognize a common essential site in the human prointerleukin 1β gene. Mol Cell Biol 14:7285, 1994
36. Zhang Y, Rom WN: Regulation of the interleukin-1β (IL-1β) gene by mycobacterial components and lipopolysaccharide is mediated by two nuclear factor-IL6 motifs. Mol Cell Biol 13:3831, 1993
37. Buras JA, Monks BG, Fenton MJ: The NF-βA-binding element, not an overlapping NF-IL-6-binding element, is required for maximal IL-1β gene expression. J Immunol 152:4444, 1994
38. Shackelford R, Adams DO, Johnson SP: IFN-γ and lipopolysaccharide induce DNA binding of transcription factor PU.1 in murine tissue macrophages. J Immunol 154:1374, 1995
39. Natsuka S, Akira S, Nishio Y, Hashimoto S, Sugita T, Isshiki H, Kishimoto T: Macrophage differentiation-specific expression of NF-IL6, a transcription factor for interleukin-6. Blood 79:460, 1992
40. Akira S, Isshiki H, Sugita T, Tanabe O, Kinoshita S, Nishio Y, Nakajima T, Hirano T, Kishimoto T: A nuclear factor for IL-6 expression (NF-IL6) is a member of a C/EBP family. EMBO J 9:1897, 1990
41. Sturm RA, Das G, Herr W: The ubiquitous octamer-binding protein Oct-1 contains a POU domain with a homeo box subdomain. Genes Dev 2:1582, 1988
42. Staudt LM, Singh H, Sen R, Wirth T, Sharp PA, Baltimore D: A lymphoid-specific protein binding to the octamer motif of immunoglobulin genes. Nature 323:640, 1986
43. Wang P, Wu P, Siegel MI, Egan RW, Billah MM: Interleukin (IL)-10 inhibits nuclear factor κ-B (NF κB) activation in human monocytes. IL-10 and IL-4 suppress cytokine synthesis by different mechanisms. J Biol Chem 270:9558, 1995
44. Yamato K, el HZ, Simon K, Koeffler HP: Modulation of interleukin-1β RNA in monocytic cells infected with human immunodeficiency virus-1. J Clin Invest 86:1109, 1990
45. Sawada M, Suzumura A, Kondo N, Marunouchi T: Induction of cytokines in glial cells by trans activator of human T-cell lymphotropic virus type I. FEBS Lett 313:47, 1992
46. Trautwein C, Caelles C, van dGP, Hunter T, Karin M, Chojkier M: Transactivation by NF-IL6/LAP is enhanced by phosphorylation of its activation domain. Nature 364:544, 1993
47. Nakajima T, Kinoshita S, Sasagawa T, Sasaki K, Naruto M, Kishimoto T, Akira S: Phosphorylation at threonine-235 by a ras-dependent mitogen-activated protein kinase cascade is essential for transcription factor NF-IL6. Proc Natl Acad Sci USA 90:2207, 1993
48. Zhang DE, Hetherington CJ, Chen HM, Tenen DG: The macrophage transcription factor PU.1 directs tissue-specific expression of the macrophage colony-stimulating factor receptor. Mol Cell Biol 14:373, 1994
49. Pahl HL, Scheibe RJ, Zhang DE, Chen HM, Galson DL, Maki RA, Tenen DG: The proto-oncogene PU.1 regulates expression of the myeloid-specific CD11b promoter. J Biol Chem 268:5014, 1993
50. Eisenbeis CF, Singh H, Storb U: PU.1 is a component of a multiprotein complex which binds an essential site in the murine immunoglobulin λ 2-4 enhancer. Mol Cell Biol 13:6452, 1993
51. Hagemeier C, Bannister AJ, Cook A, Kouzarides T: The activation domain of transcription factor PU.1 binds the retinoblastoma (RB) protein and the transcription factor TFIID in vitro: RB shows sequence similarity to TFIID and TFIIB. Proc Natl Acad Sci USA 90:1580, 1993
52. Nagulapalli S, Pongubala JM, Atchison ML: Multiple proteins physically interact with PU.1. Transcriptional synergy with NF-IL6β (C/EBPδ, CRP3). J Immunol 155:4330, 1995
53. Pongubala JM, Nagulapalli S, Klemsz MJ, McKercher SR, Maki RA, Atchison ML: PU.1 recruits a second nuclear factor to a site important for immunoglobulin κ 3′ enhancer activity. Mol Cell Biol 12:368, 1992
54. Pongubala JM, Van BC, Nagulapalli S, Klemsz MJ, McKercher SR, Maki RA, Atchison ML: Effect of PU.1 phosphorylation on interaction with NF-EM5 and transcriptional activation. Science 259:1622, 1993
55. Seeler JS, Muchardt C, Podar M, Gaynor RB: Regulatory elements involved in tax-mediated transactivation of the HTLV-I LTR. Virology 196:442, 1993
56. Clark NM, Smith MJ, Hilfinger JM, Markovitz DM: Activation of the human T-cell leukemia virus type I enhancer is mediated by binding sites for Elf-1 and the pets factor. J Virol 67:5522, 1993
57. Chen D, Rothenberg EV: Molecular basis for developmental changes in interleukin-2 gene inducibility. Mol Cell Biol 13:228, 1993
58. Tanabe O, Akira S, Kamiya T, Wong GG, Hirano T, Kishimoto T: Genomic structure of the murine IL-6 gene. High degree conservation of potential regulatory sequences between mouse and human. J Immunol 141:3875, 1988
59. Gutman A, Wasylyk B: The collagenase gene promoter contains a TPA and oncogene-responsive unit encompassing the PEA3 and AP-1 binding sites. EMBO J 9:2241, 1990
60. Jain J, McCaffrey PG, Miner Z, Kerppola TK, Lambert JN, Verdine GL, Curran T, Rao A: The T-cell transcription factor NFATp is a substrate for calcineurin and interacts with Fos and Jun. Nature 365:352, 1993
61. Wasylyk B, Wasylyk C, Flores P, Begue A, Leprince D, Stehelin D: The c-ets proto-oncogenes encode transcription factors that cooperate with c-Fos and c-Jun for transcriptional activation. Nature 346:191, 1990
62. Mukaida N, Mahe Y, Matsushima K: Cooperative interaction of nuclear factor-κB-and cis-regulatory enhancer binding protein-like factor binding elements in activating the interleukin-8 gene by pro-inflammatory cytokines. J Biol Chem 265:21128, 1990
63. Hiscott J, Marois J, Garoufalis J, D'Addario M, Roulston A. Kwan I, Pepin N, Lacoste J, Nguyen H, Bensi G, Fenton MJ: Characterization of a functional NF-κB site in the human interleukin 1β promoter: Evidence for a positive autoregulatory loop. Mol Cell Biol 13:6231, 1993
64. Iwakura Y, Saijo S, Kioka Y, Nakayama YJ, Itagaki K, Tosu M, Asano M, Kanai Y, Kakimoto K: Autoimmunity induction by human T cell leukemia virus type 1 in transgenic mice that develop chronic inflammatory arthropathy resembling rheumatoid arthritis in humans. J Immunol 155:1588, 1995
65. Umehara F, Izumo S, Ronquillo AT, Matsumuro K, Sato E, Osame M: Cytokine expression in the spinal cord lesions in HTLV-I-associated myelopathy. J Neuropathol Exp Neurol 53:72, 1994